For instance, anti-CD19 CAR T cells induced sustained, drug-free remission in patients with systemic lupus erythematosus, accompanied by autoantibody normalization and achieved clinical improvement in a case of refractory myasthenia gravis.9 This evidence concerns the gene CD19 and myasthenia gravis.